VTRS News and Press, Viatris Inc. From 11/06/25

2025-11-06 07:01:04 ET Read the full article on Seeking Alpha For further details see: Viatris Non-GAAP EPS of $0.67 beats by $0.05, revenue of $3.76B beats by $160M

Viatris Reports Third Quarter 2025 Results and Updates 2025 Financial Guidance PR Newswire Delivers Total Revenues in Line With Expectations, Reflecting Strong Execution of its Global Business Makes Late-Stage Pipeline Progress Including NDA Submission for Low-Dose Estrogen Wee...

Avidity Biosciences Inc. (RNA) is expected to report $-1.05 for Q3 2025 Universal Electronics Inc. (UEIC) is expected to report $-0.15 for Q3 2025 Intercorp Financial Services Inc. (IFS) is expected to report $1.15 for Q3 2025 Clear Secure Inc. Class A (YOU) is expected to report $0.2...

2025-11-05 12:03:31 ET More on Viatris Teva Vs. Viatris: Who Will Dominate In President Trump's America? Viatris: Indore Plant Could Boost 2026 Numbers Earnings week ahead: AMD, PLTR, PFE, O, QCOM, ENB, SHOP, MCD, UBER, SMCI, BP, LCID, MRNA, ABNB, WBD, DKNG, AMC, and...

NORTHAMPTON, MA / ACCESS Newswire / November 4, 2025 / Public policies are central factors in determining healthcare interventions and access to medicines and treatment. Viatris leverages our global experiences, scientific expertise and operations knowledge to support policymakers in identifyi...

2025-11-02 08:07:14 ET The first full week of November delivers a broad and high-impact earnings lineup across semiconductors, cloud software, AI, consumer retail, healthcare, cannabis, energy, media, and crypto-linked names, offering one of the most diversified snapshots of corporate senti...

2025-10-29 15:56:39 ET More on Amgen, Teva Pharmaceutical Teva Vs. Viatris: Who Will Dominate In President Trump's America? Teva Pharmaceutical: Turnaround Driven By Huge Pipeline Upside Teva Pharmaceuticals: Pipeline Momentum Signals New Era For Investors Ea...

NORTHAMPTON, MA / ACCESS Newswire / October 28, 2025 / Antimicrobial resistance (AMR) is a significant global health challenge impacting millions of people around the world and with the potential to lead to even greater disruptions to care if not addressed. AMR threatens the effective preventi...

2025-10-22 05:26:48 ET More on Pfizer, Johnson & Johnson, etc. AstraZeneca PLC (AZN) Presents at ESMO Congress 2025 - Slideshow Roche Holding AG (RHHBY) Shareholder/Analyst Call Transcript Roche Holding AG (RHHBY) Shareholder/Analyst Call - Slideshow Clea...

NORTHAMPTON, MA, NY / ACCESS Newswire / October 21, 2025 / Viatris has a long history in the fight against infectious disease, which accounts for eight of the top 10 causes of death in low-income countries. 1 We are working with global and local partners to help prevent infections, increase a...